Greenbrook TMS Inc
TSX:GTMS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Greenbrook TMS Inc
Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company is headquartered in Toronto, Ontario and currently employs 430 full-time employees. The company went IPO on 2018-10-03. The TMS therapy is a non-invasive therapy for the treatment of depressive disorder (MDD) and other mental health disorders. The TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. The firm's patient-focused, customer service model provides TMS therapy accessible to all patients through three business processes: Patient Inquiry; Patient Conversion; and Treatment Delivery. A course of TMS consists of 36 treatments and a course of treatment consist of an initial cortical mapping and motor threshold determination and treatment, daily treatment sessions and a subsequent motor threshold re-determination and treatment. The company operates through approximately 130 Company-operated treatment centers. The company operates across the States of North Carolina, South Carolina, Maryland, Delaware, Missouri, Illinois, and Ohio.
Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company is headquartered in Toronto, Ontario and currently employs 430 full-time employees. The company went IPO on 2018-10-03. The TMS therapy is a non-invasive therapy for the treatment of depressive disorder (MDD) and other mental health disorders. The TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. The firm's patient-focused, customer service model provides TMS therapy accessible to all patients through three business processes: Patient Inquiry; Patient Conversion; and Treatment Delivery. A course of TMS consists of 36 treatments and a course of treatment consist of an initial cortical mapping and motor threshold determination and treatment, daily treatment sessions and a subsequent motor threshold re-determination and treatment. The company operates through approximately 130 Company-operated treatment centers. The company operates across the States of North Carolina, South Carolina, Maryland, Delaware, Missouri, Illinois, and Ohio.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
